Michal Geva is the managing partner and co-founder of Triventures. Michal is one of the most prominent investors in Israel's MedTech and digital health scene. She resides on the boards of many companies and has accumulated a track record of multiple exits, including 6over6, Orthospace, and Aprica.
01:01 Where did your passion for health tech actually start?
03:42 Why did you decide to found Triventures?
09:34 Could you expand a little bit on how your model works?
11:52 Do you build a company to exit versus building a company to scale?
18:30 At what stages do you look for ventures intrapreneur ships in terms of their lifecycle?
29:01 What has changed for try ventures over the last two years in terms of the investment strategy?
38:30 What are some tips for working with investors and managing the Board of Directors?
42:06 How does an early-stage company or a company get on your radar? And what can they do at the meeting with you to come out better or not worst on the other side?
49:02 What are the unique challenges to females on the leadership side as running a VC on the one hand and as a CEO on the other?
Michal Geva is the managing partner and co-founder of Triventures. Michal is one of the most prominent investors in Israel's MedTech and digital health scene. She resides on the boards of many companies and has accumulated a track record of multiple exits, including 6over6, Orthospace, and Aprica.
01:01 Where did your passion for health tech actually start?
03:42 Why did you decide to found Triventures?
09:34 Could you expand a little bit on how your model works?
11:52 Do you build a company to exit versus building a company to scale?
18:30 At what stages do you look for ventures intrapreneur ships in terms of their lifecycle?
29:01 What has changed for try ventures over the last two years in terms of the investment strategy?
38:30 What are some tips for working with investors and managing the Board of Directors?
42:06 How does an early-stage company or a company get on your radar? And what can they do at the meeting with you to come out better or not worst on the other side?
49:02 What are the unique challenges to females on the leadership side as running a VC on the one hand and as a CEO on the other?